VIRX: Viracta Therapeutics, Inc. Stock

by  •  • Comments Off on VIRX: Viracta Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.09
Enterprise Value ($M) 6.88
Book Value ($M) -6.62
Book Value / Share -0.17
Price / Book -0.47
NCAV ($M) -6.77
NCAV / Share -0.17
Price / NCAV -0.46

Profitability (mra)
Return on Invested Capital (ROIC) -4.21
Return on Assets (ROA) -0.76
Return on Equity (ROE) -2.36

Liquidity (mrq)
Quick Ratio 0.76
Current Ratio 0.76

Balance Sheet (mrq) ($M)
Current Assets 21.80
Assets 21.96
Liabilities 28.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Forward Ventures V Lp 4.30 -66.99
11-14 13G/A Biotechnology Value Fund L P 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)

Similar Companies
VETOF – Vetoquinol SA VGLS – VG Life Sciences Inc.
VICP – Vicapsys Life Sciences, Inc. VREOF – Vireo Growth Inc.
WCUI – Wellness Center USA, Inc.


Financial data and stock pages provided by
Fintel.io